CLAZ RESEARCH & PRACTICE IN OSTEOPATHY SL
Company details
- Active NIF/CIF: B65874315
-
-
-
-
Address: CL TORRAS I BAGES,42 LOCAL 2 (PREMIA DE MAR)
-
-
Featured products:
More information on CLAZ RESEARCH & PRACTICE IN OSTEOPATHY SL
-
ZAMORA SANCHEZ JESUSAdministrador solidarioAppointment: 24/10/2012Termination of employment: 16/01/2017
-
ZAMORA SANCHEZ JESUSLiquidadorTermination of employment: 16/01/2017
-
LUCAS SALAS SERGIOAdministrador solidarioAppointment: 24/10/2012Termination of employment: 16/01/2017
-
CASANOVA CLUSELLS JORDIAdministrador solidarioAppointment: 24/10/2012Termination of employment: 16/01/2017
Other information
The CIF assigned to CLAZ RESEARCH & PRACTICE IN OSTEOPATHY SL is B65874315, and its current business status is active. The company is engaged in economic activities classified under the CNAE 8230 - Organización de convenciones y ferias de muestras, while its SIC 8299 - Escuelas y servicios educativos is also applicable. Regarding personnel, CLAZ RESEARCH & PRACTICE IN OSTEOPATHY SL employs approximately Between 10 and 49 employees and generates an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Barcelona and has a total of 5 registered positions. The latest announcement of CLAZ RESEARCH & PRACTICE IN OSTEOPATHY SL in the Borme was published on 16/01/2017, and its most recent ordinary annual accounts deposit is from the year -. To obtain contact information for CLAZ RESEARCH & PRACTICE IN OSTEOPATHY SL, such as telephone number, postal address, or website, you can visit the Company Data module. If you wish to obtain more details about CLAZ RESEARCH & PRACTICE IN OSTEOPATHY SL, you can review one of our available financial reports, examine the company's Annual Accounts, or check for any registered defaults in the RAI delinquency file. The financial, business, and legal information provided about CLAZ RESEARCH & PRACTICE IN OSTEOPATHY SL is official and updated daily.
Do you want to know more about CLAZ RESEARCH & PRACTICE IN OSTEOPATHY SL??
Find out more about this company by consulting these reports: